Drug intelligence / Profile preview

Fang Fu Gao

Development stage: Unknown
Modality: Drug Delivery Systems, Small Molecules
Administration: Topical

Overview

Fang Fu Gao is a cream containing Trolamine, a compound that exhibits properties similar to non-steroidal anti-inflammatory agents and possesses concomitant antioxidant effects. It is utilized as a topical intervention for the prevention and management of acute radiation dermatitis (ARD), a common complication experienced by breast cancer patients undergoing radiotherapy. This cream has been an established standard therapy for radiation dermatitis in Europe and the United States for over three decades.

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on Fang Fu Gao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fang Fu Gao.

Explore the full profile